Cell Therapy Human Raw Materials Market Report 2026

Cell Therapy Human Raw Materials Market Overview

• Cell Therapy Human Raw Materials market size has reached to $3.36 billion in 2025 • Expected to grow to $7.71 billion in 2030 at a compound annual growth rate (CAGR) of 17.6% • Growth Driver: Rising Adoption Of Regenerative Medicine Is Driving The Cell Therapy Human Raw Materials Market • Market Trend: Chemically Defined Mediums For Accelerated Development In The Cell Therapy Human Raw Materials Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Therapy Human Raw Materials Market?

Cell therapy human raw materials are biological substances derived from human sources, such as cells, tissues, and blood components, used as foundational elements in the development and manufacturing of cell-based therapeutic products. These raw materials are employed in various stages of cell therapy production to create treatments for diseases such as cancer, genetic disorders, and degenerative conditions. The main product types of cell therapy human raw materials are cell culture media, cell culture serum, cell culture supplements, reagents and buffers, and others. Cell culture media are solutions that provide nutrients and an environment for cell growth outside their natural setting, which is essential for lab-based cell studies. The products are used for various types of cell therapies, including dendritic cell therapy, natural killer (NK) cell therapy, stem cell therapy, and T-cell therapy, by end users such as biopharmaceutical and pharmaceutical companies, contract research organizations (CROs), and contract manufacturing organizations (CMOs), as well as academic and research institutions.

What Is The Cell Therapy Human Raw Materials Market Growth Forecast?

The cell therapy human raw materials market size is expected to see rapid growth in the next few years. It will grow to $7.71 billion in 2030 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to surge in approved cell therapy products, rising demand for allogeneic and autologous therapies, increasing regulatory scrutiny on raw material quality, expansion of commercial-scale cell therapy manufacturing, growth of oncology-focused cell therapies. Major trends in the forecast period include rising demand for xeno-free and human-derived raw materials, increasing emphasis on gmp-grade and clinical-grade inputs, growing standardization of human cell sourcing and processing, expansion of raw material requirements for advanced cell therapies, long-term supply agreements for critical human raw materials.

Global Cell Therapy Human Raw Materials Market Segmentation

1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials 2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy 3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions Subsegments: 1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells) 2) By Cell Culture Sera: Human Serum 3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides 4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants 5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP)

What Is The Driver Of The Cell Therapy Human Raw Materials Market?

The rising adoption of regenerative medicine is expected to drive the cell therapy human raw materials market going forward. Regenerative medicine refers to therapeutic approaches that repair, replace, or regenerate damaged tissues and organs using stem cells, gene therapy, tissue engineering, or other biological mechanisms to restore normal function. The adoption of regenerative medicine is increasing due to advancements in biotechnology, improved understanding of cellular mechanisms, growing demand for personalized medicine, and the ability to address unmet medical needs. The cell therapy human raw materials market supports regenerative medicine by supplying essential biological components required for producing standardized, effective, and reliable cell-based therapies. For instance, in August 2023, according to the Alliance for Regenerative Medicine, a US-based non-profit organization, there were 2,760 cell, gene, and tissue-engineering therapeutic developers worldwide in Q1 2023, up 101% from 1,369 developers in Q1 2022. Therefore, the rising adoption of regenerative medicine is driving the cell therapy human raw materials industry.

Key Players In The Global Cell Therapy Human Raw Materials Market

Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Sartorius AG, Miltenyi Biotec, Bio-Techne Corporation, STEMCELL Technologies, PromoCell GmbH, AllCells LLC, BioIVT LLC, ACROBiosystems, Sartorius CellGenix GmbH, RoosterBio Inc., Takara Bio Inc., Grifols S.A., Charles River Laboratories, WuXi AppTec, Catalent Inc., Fujifilm Cellular Dynamics Inc., Orgenesis Inc.

Global Cell Therapy Human Raw Materials Market Trends and Insights

Major companies operating in the cell therapy human raw materials market increasingly focus on developing chemically defined cell culture mediums to accelerate cell therapy development. A cell culture medium is a nutrient-rich solution designed to provide essential nutrients, growth factors, and environmental conditions necessary for cells' in vitro growth and propagation outside their natural environment. For instance, in May 2023, Lonza Group AG, a Switzerland-based healthcare manufacturing organization, launched TheraPEAK T-VIVO Cell Culture Medium. This launch features a chemically defined formulation, serum-free, and animal component-free composition, recombinant proteins, enhanced culture and expansion support, and application assistance, ensuring consistency, safety, and regulatory compliance in cell therapy manufacturing. This medium represents significant technological advancements by eliminating animal components, chemically defined formulation, and regulatory-friendly characteristics, contributing to improved safety, quality, and regulatory compliance.

What Are Latest Mergers And Acquisitions In The Cell Therapy Human Raw Materials Market?

In July 2025, Sartorius AG, a Germany‑based life science group, acquired MatTek Corp for an undisclosed amount. With this acquisition, Sartorius aims to expand its cell technology portfolio by integrating MatTek’s advanced human cell‑based microtissue models into its Lab Products & Services division, thereby strengthening its drug development platform. MatTek Corporation is a US‑based biotechnology company that specializes in developing 3D microtissue models and primary cells that more accurately mimic human tissue architecture, offering more predictive, cost‑effective, and ethical alternatives to traditional 2D cultures.

Regional Insights

North America was the largest region in the cell therapy human raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Therapy Human Raw Materials Market?

The cell therapy human raw materials market consists of sales of primary cells, stem cell banks, tissue scaffolds, cryopreservation media, cell separation products, and extracellular matrices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Therapy Human Raw Materials Market Report 2026?

The cell therapy human raw materials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy human raw materials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.